BSE filing, BSE: 544191. Summary written from the filing by ALFA Finder's alert engine.
Purple Finance Ltd: key numbers
- Share price
- ₹63.51
- Market cap
- ₹489.9 Cr
- Revenue (annual)
- ₹47.65 Cr
- Net profit (annual)
- ₹-6.44 Cr
- P/E (TTM)
- -198.4×Sector 19.7×
- Promoter holding
- 35.56%+11.10% QoQ
- FII holding
- 0.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Purple Finance Ltd
All →Purple Finance Debt & Borrowing: ₹0.16 Cr
Purple Finance paid Rs 16.44 lakh interest on its secured NCDs on the due date, October 26, 2026. TDS was deducted as per applicable law.
- Value
- ₹0.16 Cr
Purple Finance Business Update
Purple Finance plans to enter affordable housing finance and launched two new MSME-focused lending products, while sharing operational performance updates and financial highlights.
Purple Finance Q2 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Purple Finance Ltd reported revenue from operations of ₹17.3 Cr (+55.9% YoY) and net profit of ₹1 Cr for Q2 FY27.
- Key figure
- Net profit ₹1 Cr
Purple Finance Other Announcement
Purple Finance Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulation.
Purple Finance Debt & Borrowing: ₹0.17 Cr
Purple Finance Ltd successfully paid Rs.0.17 Crore as interest on its non-convertible debentures for the period ending October 2026.
- Value
- ₹0.17 Cr
Purple Finance Debt & Borrowing: ₹0.2 Cr
Purple Finance paid Rs. 0.1956 Crore interest on non-convertible debentures for the period ending October 5, 2026.
- Value
- ₹0.20 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date